Career history of Theodore A. Boutacoff
Former positions of Theodore A. Boutacoff
| Companies | Position | Start | End |
|---|---|---|---|
| IRIDEX CORPORATION | Director/Board Member | 2011-07-12 | 2011-10-10 |
| Chief Tech/Sci/R&D Officer | 2011-10-10 | 2013-01-31 | |
| Founder | 1989-01-31 | 2013-01-31 | |
| President | 2010-05-17 | 2011-10-10 | |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Director/Board Member | - | - |
Training of Theodore A. Boutacoff
| Stanford University | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 2 |
| Health Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| IRIDEX CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
